ReviewJournal of ophthalmic inflammation and infection2021

Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease.

Caleb C Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.